A randomized phase I/II study of ABT-888 in combination with temozolomide in recurrent temozolomide resistant glioblastoma: an NRG oncology RTOG group study
about
Metabolic targeting of EGFRvIII/PDK1 axis in temozolomide resistant glioblastoma.Evaluation of Concurrent Radiation, Temozolomide and ABT-888 Treatment Followed by Maintenance Therapy with Temozolomide and ABT-888 in a Genetically Engineered Glioblastoma Mouse Model.The PARP inhibitor ABT-888 potentiates dacarbazine-induced cell death in carcinoids.Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial.Clinical outcomes in recurrent glioblastoma with bevacizumab therapy: An analysis of the literature.Understanding Resistance Mechanisms and Expanding the Therapeutic Utility of PARP Inhibitors.Restricted Delivery of Talazoparib Across the Blood-Brain Barrier Limits the Sensitizing Effects of PARP Inhibition on Temozolomide Therapy in Glioblastoma.ABT-888 restores sensitivity in temozolomide resistant glioma cells and xenografts
P2860
Q33829265-8AE5C278-712F-42EF-A336-6BC7B9530A9DQ37217995-0A38D8E9-9481-471F-BCCC-40AC7474545FQ37372483-D742AD33-6BD9-4FDA-87C0-C01130D867A6Q38726649-F7F22617-E6C9-4E0F-8BC4-DF77E087F01EQ39436924-088B20EF-E942-440F-AC47-D3C058E79BEAQ41552673-3894484C-414F-4E98-ADFC-638DFE51769CQ45973213-38EEF389-C98E-4951-BD24-1DBFDC8739BCQ58699862-5B1F67D7-5957-448B-B3B0-9CE591447731
P2860
A randomized phase I/II study of ABT-888 in combination with temozolomide in recurrent temozolomide resistant glioblastoma: an NRG oncology RTOG group study
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
A randomized phase I/II study ...... NRG oncology RTOG group study
@ast
A randomized phase I/II study ...... NRG oncology RTOG group study
@en
type
label
A randomized phase I/II study ...... NRG oncology RTOG group study
@ast
A randomized phase I/II study ...... NRG oncology RTOG group study
@en
prefLabel
A randomized phase I/II study ...... NRG oncology RTOG group study
@ast
A randomized phase I/II study ...... NRG oncology RTOG group study
@en
P2093
P2860
P1476
A randomized phase I/II study ...... NRG oncology RTOG group study
@en
P2093
Andra Krauze
Andrew Y J Kee
Andy M Trotti
Arnab Chakravarti
Frank S Lieberman
H Ian Robins
Howard Colman
John F de Groot
Mark R Gilbert
P2860
P2888
P304
P356
10.1007/S11060-015-1966-Z
P50
P577
2015-10-27T00:00:00Z